Preventing Asthma in High Risk Kids
Part of paid clinical trials in Phoenix, Arizona.
- Sponsor
- Boston Children's Hospital
- Study ID
- NCT02570984
- Phase
- PHASE2
- Status
- Active Not Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 24 Months - 47 Months
- Healthy Volunteers
- Not accepted
Interventions
- Omalizumab — DRUGanti-ige injection
- Placebo — DRUGplacebo comparator arm, injection similar to active
Study Details
This trial is a randomized, double-blind, placebo controlled trial designed to test whether two years treatment of preschool children aged 2-3 years of age at high risk for asthma with omalizumab (anti-IgE) for two years will prevent the progression to childhood asthma, as reflected by a reduction in the prevalence of active asthma in the Final 12 months during 2 year observation period off study drug.
Key Dates
- Start date
- Nov 27, 2018
- Status verified
- Dec 2025
- Primary completion
- Jan 31, 2028
- Completion
- Mar 31, 2028
Study Design
- Enrollment
- 200 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- Active Comparator: Activeomalizumab 0.016 mg/kg/IU total IgE
- Placebo Comparator: Placebolooks like active drug
Primary Outcome Measure
active asthma diagnosis [ Time Frame: Final 12 months during 2 year observation period off study drug ]
Locations (13)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Phoenix Children's Hospital | Phoenix | Arizona | 85016 | - |
| Rady Children's Hospital - San Diego | San Diego | California | 92123 | - |
| Childrens Hospital Colorado | Aurora | Colorado | 80045 | - |
| Connecticut Children's Hospital | Hartford | Connecticut | 06106 | - |
| Children's National Medical Center | Washington D.C. | District of Columbia | 20010 | - |
| Emory University | Atlanta | Georgia | 30322 | - |
| Ann & Robert H. Lurie Children's Hospital of Chicago | Chicago | Illinois | 60611 | - |
| Indiana University/Riley Children's Hospital | Indianapolis | Indiana | 46202 | - |
| Boston Children's Hospital | Boston | Massachusetts | 02115 | - |
| Washington University | St Louis | Missouri | 63110 | - |
| Cincinnati Children's Hospital Medical Center | Cincinnati | Ohio | 45229 | - |
| Texas Children's Hospital/Baylor College of Medicine | Houston | Texas | 77030 | - |
| University of Wisconsin | Madison | Wisconsin | 53792 | - |
Find similar trials in Phoenix, AZ
By condition
By specialty
Related Studies
- Mechanism(s)of Airflow Limitation in Moderate-severe Persistent AsthmaRecruiting · Gelb, Arthur F., M.D. · Lakewood, California
- Pilot Study to Identify the Mediators and Inflammatory Cell Surface Receptors Involved in Allergic Airway InflammationPHASE1 · Recruiting · Benjamin Medoff · Boston, Massachusetts
- Mechanism(s) of Airflow Limitation During Exacerbation of AsthmaPHASE4 · Recruiting · Gelb, Arthur F., M.D. · Lakewood, California
- Asthma Inflammation ResearchEARLY_PHASE1 · Enrolling By Invitation · The Cleveland Clinic · Cleveland, Ohio